ARDT vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, and VCYT
Should you be buying Ardent Health stock or one of its competitors? The main competitors of Ardent Health include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
Ardent Health vs. Its Competitors
Guardant Health (NASDAQ:GH) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.
In the previous week, Guardant Health had 6 more articles in the media than Ardent Health. MarketBeat recorded 11 mentions for Guardant Health and 5 mentions for Ardent Health. Guardant Health's average media sentiment score of 0.86 beat Ardent Health's score of 0.45 indicating that Guardant Health is being referred to more favorably in the media.
Ardent Health has a net margin of 3.73% compared to Guardant Health's net margin of -53.82%. Ardent Health's return on equity of 16.07% beat Guardant Health's return on equity.
92.6% of Guardant Health shares are held by institutional investors. 6.1% of Guardant Health shares are held by company insiders. Comparatively, 1.7% of Ardent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Ardent Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.
Guardant Health currently has a consensus price target of $53.76, indicating a potential upside of 6.99%. Ardent Health has a consensus price target of $20.67, indicating a potential upside of 54.62%. Given Ardent Health's higher probable upside, analysts plainly believe Ardent Health is more favorable than Guardant Health.
Summary
Ardent Health beats Guardant Health on 9 of the 15 factors compared between the two stocks.
Get Ardent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ardent Health Competitors List
Related Companies and Tools
This page (NYSE:ARDT) was last updated on 7/4/2025 by MarketBeat.com Staff
Free ARDT Stock Alerts